GW&K Investment Management LLC Sells 48,675 Shares of Novanta Inc. $NOVT

Key Points

• GW&K Investment Management LLC sold 48,675 shares of Novanta, reducing its stake by 15.9% to 256,541 shares valued at about $25.69 million at the end of the quarter.
• Several large institutional moves include Congress Asset Management's new ~$59.15 million stake and Mawer Investment Management boosting holdings by 1,114.5% to 391,148 shares, leaving institutional investors owning 98.35% of the stock.
• Analysts have an average rating of Hold with an average price target of $150, while Novanta slightly beat quarterly EPS estimates ( $0.91 vs $0.88 ) and set FY2026 guidance of $3.50–$3.65 EPS and Q1 guidance of $0.75–$0.80.

GW&K Investment Management LLC lessened its holdings in shares of Novanta Inc. (NASDAQ:NOVT - Free Report) by 15.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 256,541 shares of the technology company's stock after selling 48,675 shares during the period. GW&K Investment Management LLC owned 0.72% of Novanta worth $25,693,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Congress Asset Management Co. bought a new stake in Novanta during the 3rd quarter worth about $59,153,000. Mawer Investment Management Ltd. lifted its holdings in Novanta by 1,114.5% during the 3rd quarter. Mawer Investment Management Ltd. now owns 391,148 shares of the technology company's stock worth $39,173,000 after buying an additional 358,941 shares in the last quarter. Norges Bank acquired a new stake in shares of Novanta in the 2nd quarter valued at $29,982,000. Brown Advisory Inc. raised its position in shares of Novanta by 8,526.6% during the second quarter. Brown Advisory Inc. now owns 220,409 shares of the technology company's stock worth $28,417,000 after acquiring an additional 217,854 shares during the last quarter. Finally, Bamco Inc. NY raised its position in shares of Novanta by 202.3% during the second quarter. Bamco Inc. NY now owns 311,115 shares of the technology company's stock worth $40,112,000 after acquiring an additional 208,188 shares during the last quarter. 98.35% of the stock is owned by institutional investors.

Analyst Ratings Changes

NOVT has been the topic of a number of research reports. Robert W. Baird set a $150.00 target price on shares of Novanta in a research report on Wednesday, February 25th. Zacks Research raised shares of Novanta from a "strong sell" rating to a "hold" rating in a research note on Friday, January 16th. Finally, Weiss Ratings raised shares of Novanta from a "sell (d+)" rating to a "hold (c-)" rating in a report on Tuesday, January 20th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $150.00.

Novanta Price Performance

Shares of NOVT stock opened at $136.59 on Friday. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. Novanta Inc. has a 12-month low of $98.27 and a 12-month high of $149.95. The firm has a fifty day moving average of $134.71 and a 200-day moving average of $120.92. The firm has a market capitalization of $4.87 billion, a price-to-earnings ratio of 93.55 and a beta of 1.61.

Novanta (NASDAQ:NOVT - Get Free Report) last released its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.03. Novanta had a return on equity of 13.12% and a net margin of 5.49%.The business had revenue of $258.35 million for the quarter, compared to analysts' expectations of $260.72 million. During the same quarter in the previous year, the business posted $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, equities research analysts forecast that Novanta Inc. will post 3.03 earnings per share for the current year.

Insider Buying and Selling at Novanta

In other Novanta news, CFO Robert Buckley sold 1,423 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $140.88, for a total transaction of $200,472.24. Following the completion of the transaction, the chief financial officer owned 93,814 shares in the company, valued at approximately $13,216,516.32. This represents a 1.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Matthijs Glastra sold 7,500 shares of the business's stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the sale, the chief executive officer owned 57,367 shares in the company, valued at approximately $8,320,509.68. This trade represents a 11.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 24,346 shares of company stock valued at $3,382,737 in the last three months. 1.20% of the stock is owned by insiders.

Novanta Company Profile

Novanta, Inc NASDAQ: NOVT is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.

Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.